Disinfectant Qualification Bacteria, Fungi, Viruses and Atypical Organisms A Step by Step Workshop

Similar documents
Disinfectant Qualification and Cleanroom Disinfection A Step by Step Workshop

Good Microbiology Laboratory Practices

Environmental Monitoring Deficiencies

Pre-Sterilization Bioburden Failures and Causes

ADVANCED COURSE IN THE IDENTIFICATION OF FUNGI

Key Elements of a Microbial Contamination Control Policy Why and how to write a policy for Microbial Contamination Control

March 14th, 2014 * San Juan, Puerto Rico Identifying, Preventing, Controlling, Investigating and Remediating Mold Contamination

Why Disinfectant Qualification Studies Fail

Investigating Non-Sterile Product Bioburden Failures

Auditing Cleanroom Gown Suppliers

Microrite, Inc. brings you this unique learning experience in Fungal Identification Simplified E-Workshop; Part of

Mold Contamination-Do's and Don'ts

Auditing Cleanroom Gown Suppliers (Europe & Middle East)

Auditing Cleanroom Gown Suppliers

Mold Contaminations-Prevention, Investigation, Remediation and Risk Assessment Durham, NC September 17 th & 18 th, 2018

Understanding Microbial Control in In-Vitro Diagnostics

Understanding Microbiology Related Data Integrity Issues and Their Causes

Auditing Microbiology Media Suppliers

Strategy for Investigating Microbial Contaminations

Contamination Risk Assessment in Aseptic, Non-Sterile and Terminally Sterilized Products March 7 th & 8 th Raleigh, NC

EU GMP ANNEX 1 DRAFT CLARIFICATION AND IMPACT

Pharmacopoeial Antimicrobial Effectiveness Testing

Microbial Detection Methods and Their Limitations

Pharmaceutical Water System Sampling The Why s, Where s, and How s of Doing It Right

Chemical Sterilization - Alternate Sterilization Methods

Environmental Monitoring Requirements and Best Practices for Medical Devices and Drugs New AAMI and ISO EM Reference Documents and Standards

Stability Testing for Pre-Clinical and Early Phase Clinical Drug Products

EU GMP ANNEX 1 CHANGES CLARIFICATION AND IMPACT

CONVENTIONAL AND ALTERNATE STERILIZATION METHODS

MICROBIAL LIMIT TESTS FOR RAW MATERIALS AND NON-STERILE PRODUCTS REVIEW-DISCUSSIONS-INTERPRETATIONS

Cleaning Validation-Common Errors

Considerations when choosing a LIMS System

Risk Based Incoming Quality Assurance (IQA)

Microbial Contamination Testing and Validation Challenges Non-Sterile Products and Raw Materials

Microrite, Inc. brings you this unique learning experience in Biofilm Basics; Part of Microrite s step-by-step webinar series.

Cleaning-Disinfection-Sterilization of Reusable Medical Devices

Technology Transfer Critical Points to Consider

Biofilms in Water Systems - Reasons and Solutions

Process Validation for FDA Regulated Industries

Cleaning-Sterilization-Disinfection Validation of Reusable Medical Devices

Filling and Packaging Validation for FDA Regulated Industries

Supplier Relationship Management

Facility Water Management

Microrite, Inc. brings you this unique learning experience in microbial contamination investigations; part of Microrite s Practical Series Seminars.

Understanding GxP (GMP, GCP & GLP) for FDA Regulated Industries

NEW! Processing of cgmp Controlled Raw Materials

Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues

Designing and Sustaining New and Existing Product Stability Testing Program

Disinfectant Qualification A Multifaceted Study

Avoiding Microbiological Media Related Failures

Conducting a Risk Assessment for Non-Sterile Facilities E-Workshop

Current Moist Heat Sterilization and Validation Seminar

Understanding and Testing Compressed Gases

Hot Topics in Drug Product Process Validation: A Reviewer s Perspective

Understanding and Testing Compressed Gases

Study Title Determination of the Antiviral Effectiveness of KHG FiteBac Technology Test Substance Delivered via Pipette Against MS2 Bacteriophage

Training Prospectus Public Course Dates

Overview of a sterility assurance program for PET drugs

Responses to Questions for SYSTEM 1E Process Monitoring and Validation Webinar

SOPs for FDA-Regulated Industry Best Practices to Withstand FDA Expectations

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

PDA Bioburden and Biofilm Workshop

Study Title Antibacterial Activity and Efficacy of KHG FiteBac Technology Test Substance Using a Suspension Time-Kill Procedure

A Practical Introduction to Sterile Manufacturing 25th September 2018 Nailcote Hall Hotel Warwickshire

Modern Validation Technology Boot Camp

Seminar on Pre-clinical safety evaluation of vaccines: current experience, new adjuvants and future challenges

MICROBIOLOGICAL CULTURE MEDIA

Application for Assessment of Educational Qualifications and Skilled Employment

Guidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE

Bio-Burden Reduction in Biological Laboratories

Aseptic Process Validation

CLEANING & SANITATION IN FOOD PLANTS

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

Cleaning Efficiency of The MicroOne Wipe and Mop Cleaning System

The Caribbean Association of Judicial Officers Conference Port of Spain, Trinidad June 25 27, 2009

Test Method for Efficacy of Copper Alloy Surfaces as a Sanitizer

BIOPHARMACEUTICAL PROCESS EVALUATED FOR VIRAL CLEARANCE

for IND and RDRC Regulated PET Compounding

Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces

The Parenteral Drug Association

2nd Annual Workshop and Conference: March 15 th & 16 th, Omni Hotel, New Haven, CT. Get Connected. Be Inspired.

Pharmaceutical Compounding Sterile and Nonsterile Preparations. Jeanne Sun, PharmD

SKILLED MIGRATION ASSESSMENT APPLICATION FORM 2016

REQUEST FOR HEMOPHILIA B (FACTOR IX DEFICIENCY)

Current Industry Trends -Including Cleaning and Disinfection trends, Disinfectant Validation Trends, and Current Warning Letter Activity.

Cost-effective Purification of Vaccines, Data Integrity Systems and CTDs. DRAFT AGENDA Rio de Janeiro, 18 to 20 June 2018

The Most Probable Number Method and Its Use in QC Microbiology

CGMP for 21 st Century : A Risk-based Approach (Quality by Design)

Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH)

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Our capabilities are your advantage

Design and Construction of Biocontainment Laboratories

ANALYTIC METHODS FOR SOLVING ASSET MANAGEMENT DECISION PROBLEMS MANAGING AGING INFRASTRUCTURE, PROJECT VALUATION, AND PORTFOLIO MANAGEMENT

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

UF/MF Membrane Water Treatment

Environmental Monitoring of Aseptic Processing Areas - 2

SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations

Microbiology Research Associates

Farm Analysis Solution Tools Tools for Better Decisions. A workshop for producers and agribusiness professionals who use FAST.

Microbiological Cleaning Method Validation

Transcription:

Microrite, Inc. brings you this unique advanced course in ; part of Microrite s Step by Step Workshop Series Participate in the only workshop which will guide you through the process of choosing a cost effective and compliant disinfectant qualification method, which suites your company budget, personnel availability, urgency and time limit Also learn how to plan study execution schedule and supplies, how to budget costs, and how to execute each step and assess errors that may occur This workshop will also cover data analysis, establishing expiry dates for diluted and undiluted disinfectants and how to apply the findings to the cleaning procedures Do not miss this opportunity if planning a disinfectant qualification study or have performed one and wish to verify it Learn from the case studies presented at this workshop. Additionally learn about using viruses and atypical microorganisms. Understand the methods used for the organism cultivation as well as technicalities associated with eliminating false positive results during disinfectant qualification studies using viruses. Which industries does this seminar apply to? Industries that will benefit from this training are Pharmaceuticals, Biotechnology, Medical Device, and In Vitro Diagnostics Who will benefit? Microbiologists performing, and reviewing Studies, Quality Assurance, Regulatory and Manufacturing personnel

DAY 1 Disinfectants commonly used in the industry, their modes of action, efficacy, and toxicity Understanding the nature of contaminants in the cleanroom and which disinfectants will be effective against them Overview of the many methods and variations used for disinfectant qualifications o Tube dilution method Using filtration Using neutralizing broth o Representative Hard Surfaces Using contact plates Using Swab Recovery Method Using Rinse Method Using Neutralizing Broth Using Sonication Discussions on the variants of each of the methods and the benefits and shortcomings of each method Discussion on the pitfalls expected when choosing each method available Protocol o Guidance on drafting a Disinfectant Study Protocol for each of the methods discussed Planning the Study-Scheduling and Costs o Using planning templates, guidance will be provided for breaking up the study components to manage scheduling, costing and ordering supplies to avoid waste due to expiry of media and buffers Managing personnel o Planning each section of protocol for execution o Planning of daily activities while maximizing testing Method Validation for Bacteria and Fungi o How to validate each method o What to look for as acceptance criteria Recovery Study o Guidance on how to perform swabbing studies to get maximum recovery o How to plan a recovery study for various methods of efficacy testing o Understand the facts and myths about recoveries Bonus Session: Wet disinfection vs. dry decontamination Dry decontamination of manufacturing facilities Wet disinfection vs. dry decontamination Overview of fogging technologies Case studies of dry decontamination of food producing plants

DAY 2 Efficacy Testing o Points to consider when planning an efficacy study o How to mitigate inoculum count drop o Application of inoculum and disinfectants-what to pay attention to o Log reduction calculation Time 0 Verification o Understand why this additional step gives more confidence in the data generated from the efficacy study Expiry Dating Study for Disinfectants o How to review efficacy data to abbreviate expiry study which will generate dependable results for assigning expiry date for pre-diluted disinfectants and concentrated disinfectants that do not have an expiry assigned by the manufacturer Log Reduction Calculation o Data analysis o Common errors o Detecting false positive or false negative log values Reviewing Data o How to identify execution errors when reviewing data. Establish and Implement corrective actions Overview of testing disinfectants using biofilms Translation of disinfectant qualification results to cleaning procedures to prevent contamination o Cleaning procedures-what should be addressed o How to monitor efficacy of the cleaning program Commonly observed deficiencies in studies that may lead to contamination or FDA observations Sanitization Studies/ using Viruses and Atypical Microorganisms Growing viruses-points to consider o Eliminating False Positives during the sanitization studies o Pre-requisite testing to be performed for the viruses and cell lines (used for the viral cultivation) prior to the initiation of the viral sanitization studies. o Recovery Testing and Sanitization Study Qualification Testing o Challenges for defining the appropriate dilution of neutralizer that will not affect the cells or viruses o Choice of Testing Method to be used for the virus sanitization study testing. Growing Atypical Bacteria-points to consider. Defining the testing sequence and methodology to be used for the study. Testing process and modification of some parameters for a successful recovery testing. Use of a different medium for bacterial cultivation. Length of incubation. Process of bacterial elution from spiked substrates (sonication versus scraping or vortexing etc) Protocol Points to consider

VENUE AND CONFERENCE AGENDA September 13 th & 14 th,2012 MIT ENDICOTT HOUSE 80 Haven Street Dedham, MA 02026 PROGRAM Day 1 (September 13 th, 2012) Registration and Breakfast 8.00 AM to 8.30 AM Overview of Disinfectants 8.30 AM to 10.00 AM Break 10.00 AM to 10.15 AM Overview of Methods 10.30 AM to 12.00 AM Lunch 12.00 PM to 1.00 PM Planning the Study and Study Details 1.00 PM to 3.00 PM Break 3.00 PM to 3.15 PM Wet disinfection vs. dry decontamination 3.15 PM to 4.15 PM Questions and Answers 4.15 PM to 5.00 PM Day 2 (September 14 th, 2012) Breakfast 8.00 AM to 8.30 AM Efficacy Testing Details for Planktonic and Biofilm 8.30 AM to 10.00 AM Microorganisms Break 10.00 AM to 10.15 AM Data Review and 483 Observations 10.15 AM to 11.45 PM Questions and Answers 11.45AM to 12.00 PM Lunch 12.00 PM to 1.00 PM using Viruses and Atypical Organisms 1.00 PM to 3.00 PM Coffee Break 3.00 PM to 3.15 PM Challenges in growing Viruses and Atypical Organisms 3.00 PM to 4.00 PM Protocol Considerations 3.45 PM to 4.15 PM Questions and Answers 4.15 PM to 5.00 PM Endicott House is not your ordinary Endicott House is not your ordinary conference center in Boston. Built in 1934 and surrounded by numerous acres of magnificent gardens, Endicott House mansion's French manor style defines the merging of historic refinement and modern amenities. The estate is located in a secluded setting on 25 acres. The sleeping rooms in this mansion are one of a kind with antique décor. They offer fine food, and exceptional service. This unique conference center venue is minutes from Boston.

REGISTRATION FORM Personal Information of One Registrant Last Name: Mr. Ms. Dr. First Name: Title: Organization: Mailing Address: Telephone: Email: Fee: $1800.00 per attendee (Includes 2 day seminar fee, breakfast, lunch, break for all days, and course material) Additional Attendees Method of Payment: Credit Card and Check payments only. Attendees can register and make payments on Microrite s website-www.microrite.com or complete this form and fax to 408-445-1236. Check payments must be cleared before the seminar date. If you have any questions regarding payment methods feel free to contact Microrite at 408-445-0507 or send your enquiry to info@microrite.com. Confirmation of registration will be sent via email. For credit card payment on website, a payment receipt will be considered as confirmation of registration. For credit card information faxed to Microrite an email confirmation will be sent with a copy of payment receipt. Please call 408-445-0507 in due time if confirmation is not received after payment. Hotel Accommodation **Only 10 mansion rooms available! MIT Endicott House 80 Haven Street, Dedham, MA 02026 www.mitendicotthouse.org Phone: 781-326-5151 or 781-251-6363.

PAYMENT INFORMATION Choose One (Place X) VISA Master Card American Express Card Holder s Name Address of Card Holder: Enter firm address for corporate card or personal address for personal card Street: City: Zip Code: Country: Contact Ph No & Email: Card Number: Expiration(Month/Year): Name on Card: Amount (US Dollars): Signature: Name of Attendee(s) Referred by: Kindly note the name of the company or person that referred you to this workshop. We would like to thank them..

Our presenters are experts in their fields and passionate about teaching! Jon Ruppert is Eastern Regional Manager for Mar Cor Purification. Prior to Mar Cor Purification Jon worked 8 years with Siemens Water Technologies in the Pharmaceutical High Purity Process Water Business running their BioPharm Market Team as well handling Strategic Accounts. Prior to Siemens Water Jon worked for 10 years for STERIS Corporation in their Life Sciences and Healthcare Businesses with experiences in Marketing, Strategic Planning and Research and Development. Jon s thirty plus years of experience includes water purification, hard surface disinfection, vapor and dry fog disinfection, steam sterilization and multiple effect distillation and pure steam generation. Ziva Abraham has over 25 years of academic, research, clinical and industrial experience in Microbiology, and Quality Assurance. She has trained personnel from various industries in microbiology techniques and methods. Ziva has received her Master s Degree in Microbiology and has conducted research on developing Microbial Insecticides. She has established clinical laboratory systems in Israel, Microrite, Inc. a consulting company based in San Jose, CA and Microrite Training Center in Santa Clara, CA. Microrite helps Pharmaceutical, Medical Device, Biotechnology and Combination Product Companies, and In-Vitro Diagnostics in the areas of Quality Assurance, Validation, Process Development and Microbiological Quality Control. She is a known microbial contamination control expert who is teaching disinfectant qualification internationally using her hands on experience in performing numerous disinfectant qualification studies and reviewing study data to assess validity and applicability of the data for establishing cleaning programs. Ziva also is a known mycologist teaching hands on fungal identification and investigating mold contaminations in facility, process and product. Charity Ogunsanya is the Director of Quality Control at Aeras (Tuberculosis Vaccine Research and Development Company) with overall responsibility for the Quality Control testing Laboratory. She has over 21+ years of extensive experience not limited to Aseptic Processing, Contamination Control, Quality Control, Microbiology, Sterility Assurance, Quality Assurance, Vaccine Development, Product Design, Testing and Validation. She is also vast in both national and international regulatory bodies requirements such as the FDA, EMEA, EU, TGA, JP, ISO etc. She has extensive industry experiences within the Biologics, Pharmaceuticals, Radiopharmaceuticals, Biotechnology and Medical Device Industries. Charity also consults for the Gerson Lehrman Group (GLG), Intota Expert Network, and Zintro Expert Network which are all high level international professional expert network consulting corporations targeted towards investment banking operations and other corporations..